Business Context and Reporting Period
This Form 8-K Current Report was filed by 180 Life Sciences Corp. (not Forum Markets Inc.) on August 2, 2021, covering events occurring on July 31, 2021. The filing details the resolution of a dispute with Alpha Capital Anstalt regarding a Senior Secured Convertible Promissory Note and a Securities Purchase Agreement entered into in September 2020.
Key Financial Metrics and Transaction Details
The filing does not provide standard financial metrics such as revenue, profit, cash flow, or liquidity ratios. The primary financial event reported is a debt settlement involving the following terms:
- Debt Instrument: A 10% Senior Secured Convertible Promissory Note with an original principal amount of $1,111,111.
- Settlement Consideration: The Note and all related amounts, penalties, and fees were exchanged for 150,000 shares of common stock ("Conversion Shares") and a warrant to purchase 25,000 shares.
- Warrant Terms: Exercise price of $7.07 per share; expiration date of August 2, 2024; subject to a 4.99% ownership limitation (expandable to 9.99% with notice).
- Registration Obligation: The Company agreed to file a registration statement for the Conversion Shares and warrant shares by August 2, 2021.
Material Changes Versus Prior Period
This filing represents a discrete event rather than a periodic financial update. The material change is the extinguishment of the outstanding debt obligation to Alpha Capital Anstalt and the corresponding issuance of equity securities. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, revenue outlook, or management commentary regarding future operations. The primary risk and contingency addressed is the resolution of the default and dispute with Alpha Capital Anstalt, which has been settled via a mutual release. The Company claims an exemption from registration under Section 3(a)(9) of the Securities Act for this exchange.
Key Facts for Investor Verification
- Verify the actual issuance of the 150,000 Conversion Shares and the 25,000-share warrant to Alpha Capital Anstalt.
- Confirm the filing of the registration statement for these shares by the August 2, 2021 deadline.
- Review the impact of the 4.99% ownership limitation on the warrant's exercisability.
- Note that the registrant is 180 Life Sciences Corp. (Ticker: ATNF), not Forum Markets Inc.